Scaling Digital Health Research: Insights and Lessons Learned From a Multi-Year Industry-Academia Collaboration
Clare Kennedy Purvis, PsyD
Senior Manager, Clinical Product and Coaching
Women Entrepreneurs and Leaders Lab (WELL)
Computerized Assessment of Mental Status (CAMS): A Novel Tool for Objective Quantification of Clinically Relevant Behavior in Psychiatry
Joshua Woolley, MD, PhD
Assistant Professor of Psychiatry
UCSF Weill Institute for Neurosciences
About speaker #1:
Clare leads Clinical Product and Coaching at Lantern, a mental health technology startup delivering app-based, human-supported digital CBT interventions for adults with anxiety, depression, and eating disorders. She completed her doctorate in clinical psychology at the PGSP - Stanford Consortium, where her dissertation at the Stanford Virtual Human Interaction Lab used virtual reality to create a behavioral measure of body image disturbance among college women. As a psychologist at a mental health tech startup, Clare creates clinical programs, conducts research, and applies behavior science to inform user experience and design.
Clare is also the founder of the Women Entrepreneurs & Leaders Lab (WELL), a community-centered career accelerator for women healthcare professionals in industry. WELL is dedicated to supporting women as leaders in health tech by providing the community, resources, and opportunities needed to translate clinical and scientific expertise into impactful careers in industry. She is fascinated by the intersection of technology and mental health, and believes in the potential for tech innovation to radically improve healthcare in the United States.
About speaker #2:
Josh Woolley MD, PhD, is an Assistant Professor in Residence in the Department of Psychiatry at the University of California, San Francisco (UCSF) and a staff psychiatrist in Mental Health at the San Francisco Veterans Affairs Medical Center (SFVAMC). Dr. Woolley received his MD/PhD in Neuroscience from UCSF. Early on in his career he recognized the importance of social support in recovery from psychiatric disorders such as posttraumatic stress disorder (PTSD), alcohol use disorder (AUD), substance use disorder, and schizophrenia and decided to focus his research on trying to understand and treat the pervasive social deficits in psychiatric disorders.
He is the Director of the Bonding and Attunement in Neuropsychiatric Disorders (BAND) lab, which focuses on developing and testing novel pharmacologic and behavioral treatments for these disorders with the hopes of improving real world social functioning and overall quality of life. One of the main branches of his research focuses on understanding the effects of oxytocin on alleviating social deficits and substance use cravings, as well as increasing group cohesion and social connection in multiple clinical and non-clinical populations. Recently, he and his team have also begun to explore the potential for mobile interventions to alleviate the hard to treat symptoms of co-occurring PTSD and AUD as well as social cognitive deficits in schizophrenia.
Finally, Dr. Woolley recently initiated a third branch of work that examines the potentially beneficial effects of psilocybin-enhanced group therapy for demoralization and complex trauma in long-term AIDS survivors as well as the potentially beneficial effects of MDMA psychotherapy for PTSD. In addition to conducting multiple large randomized controlled studies on novel treatments for a variety of psychiatric disorders, Dr. Woolley is also working on developing and validating the Computerized Assessment of Mental Status (CAMS) in collaboration with a computer scientist at the University of Southern California, Stefan Scherer. CAMS is a tool to objectively and quickly characterize social-emotional behavior and the hope is it could be developed into a "chemistry panel for psychiatry". This exciting new project has the potential to revolutionize how we assess and quantify emotional behavior in clinical and research settings.
About this seminar series:
We are pleased to continue this monthly seminar series focusing on the use of digital health technologies in mental health. Our intention is to bring together researchers across campus interested in this topic, with the hope of learning about current approaches being used, understanding how existing approaches could be enhanced, and potentially fostering new collaborations.
Each 90-minute seminar will feature someone in academia using digital health technologies in their work, followed by a similar chat by someone in industry nominated by peers at UCSF whose work is considered especially compelling in this space.
To better serve the community, this seminar will be broadcast via WebEx to:
Monday, March 26, 2018 at 3:30pm to 5:00pm
401 Parnassus Ave., San Francisco, CA 94143